Literature DB >> 17115324

Dentin alteration of deciduous teeth in human hypophosphatemic rickets.

T Boukpessi1, D Septier, S Bagga, M Garabedian, M Goldberg, C Chaussain-Miller.   

Abstract

Familial hypophosphatemic rickets is in most cases transmitted as an X-linked dominant trait and results from mutation of the PHEX gene, predominantly expressed in osteoblast and odontoblast. Patients have been reported to display important dentin defects, and therefore, we explored the dentin structure, composition, and distribution of extracellular matrix (ECM) molecules in hypophosphatemic human deciduous teeth. Compared to age-matched controls, the dentin from hypophosphatemic patients exhibited major differences: presence of large interglobular spaces resulting from the lack of fusion of calcospherites in the circumpulpal dentin; defective mineralization in the interglobular spaces contrasting with normal Ca-P levels in the calcospherites on X-ray microanalysis; abnormal presence of low-molecular weight protein complexes recognized on Western blots by antibodies against matrix extracellular phosphoglycoprotein (MEPE), dentin sialoprotein, osteopontin, and reduced osteocalcin (OC) level; and accumulation in the interglobular spaces of immunolabeling with antibodies against DSP, dentin matrix protein, bone sialoprotein, MEPE and OC, while chondroitin/dermatan sulfate glycosaminoglycans were exclusively located inside calcospherites. Alterations of the post-translational processing or partial degradation of some ECM appear as key factors in the formation of the defective hypophosphatemic dentin.

Entities:  

Mesh:

Year:  2006        PMID: 17115324     DOI: 10.1007/s00223-006-0182-4

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  33 in total

Review 1.  The rachitic tooth.

Authors:  Brian L Foster; Francisco H Nociti; Martha J Somerman
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

2.  Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.

Authors:  Erik A Imel; Francis H Glorieux; Michael P Whyte; Craig F Munns; Leanne M Ward; Ola Nilsson; Jill H Simmons; Raja Padidela; Noriyuki Namba; Hae Il Cheong; Pisit Pitukcheewanont; Etienne Sochett; Wolfgang Högler; Koji Muroya; Hiroyuki Tanaka; Gary S Gottesman; Andrew Biggin; Farzana Perwad; Meng Mao; Chao-Yin Chen; Alison Skrinar; Javier San Martin; Anthony A Portale
Journal:  Lancet       Date:  2019-05-16       Impact factor: 79.321

3.  Dual role of the Trps1 transcription factor in dentin mineralization.

Authors:  Maria Kuzynski; Morgan Goss; Massimo Bottini; Manisha C Yadav; Callie Mobley; Tony Winters; Anne Poliard; Odile Kellermann; Brendan Lee; Jose Luis Millan; Dobrawa Napierala
Journal:  J Biol Chem       Date:  2014-08-15       Impact factor: 5.157

4.  ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate.

Authors:  Valentin David; Aline Martin; Anne-Marie Hedge; Marc K Drezner; Peter S N Rowe
Journal:  Am J Physiol Renal Physiol       Date:  2010-12-22

Review 5.  Tooth dentin defects reflect genetic disorders affecting bone mineralization.

Authors:  S Opsahl Vital; C Gaucher; C Bardet; P S Rowe; A George; A Linglart; C Chaussain
Journal:  Bone       Date:  2012-01-26       Impact factor: 4.398

6.  Abnormal presence of the matrix extracellular phosphoglycoprotein-derived acidic serine- and aspartate-rich motif peptide in human hypophosphatemic dentin.

Authors:  Tchilalo Boukpessi; Celine Gaucher; Thibaut Léger; Benjamin Salmon; Julie Le Faouder; Cyril Willig; Peter S Rowe; Michèle Garabédian; Olivier Meilhac; Catherine Chaussain
Journal:  Am J Pathol       Date:  2010-06-25       Impact factor: 4.307

7.  Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.

Authors:  Aline Martin; Valentin David; Jennifer S Laurence; Patricia M Schwarz; Eileen M Lafer; Anne-Marie Hedge; Peter S N Rowe
Journal:  Endocrinology       Date:  2007-12-27       Impact factor: 4.736

8.  Expression and processing of small integrin-binding ligand N-linked glycoproteins in mouse odontoblastic cells.

Authors:  Shuo Chen; Lei Chen; Allen Jahangiri; Bo Chen; Yimin Wu; Hui-Hsiu Chuang; Chunlin Qin; Mary MacDougall
Journal:  Arch Oral Biol       Date:  2008-06-26       Impact factor: 2.633

9.  Dentin noncollagenous matrix proteins in familial hypophosphatemic rickets.

Authors:  Céline Gaucher; Tchilalo Boukpessi; Dominique Septier; Frédéric Jehan; Peter S Rowe; Michèle Garabédian; Michel Goldberg; Catherine Chaussain-Miller
Journal:  Cells Tissues Organs       Date:  2008-08-14       Impact factor: 2.481

10.  Periodontal breakdown in the Dmp1 null mouse model of hypophosphatemic rickets.

Authors:  L Ye; S Zhang; H Ke; L F Bonewald; J Q Feng
Journal:  J Dent Res       Date:  2008-07       Impact factor: 6.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.